Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial
BioMetals · 2024
DOI: 10.1007/s10534-024-00630-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BioMetals, 2024. Verfasst von Kasra Jahankhani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Multiple Myeloma, Zinc, Hematopoietic Stem Cell Transplantation, Dietary Supplements. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Hematopoietic stem cell research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract (Originalsprache)
Multiple myeloma (MM) patients are often accompanied by heightened levels of oxidative stress, even following bone marrow transplantation. Trace mineral supplements have been found to regulate and inhibit the activity of oxidative radicals and inflammatory factors, which are involved in the pathogenesis of MM. The study sought to evaluate the effectiveness of the supplementation by analyzing changes in oxidative, anti-oxidative, and inflammation markers. Patients were randomly assigned to a zinc or placebo group, with the former receiving 30 mg of zinc or placebo tablets daily for 1 month. Blood samples were collected from the patients on the day of transplantation, 15 days, and 30 days post-transplantation. Real-time PCR was employed to measure the expression of oxidative/antioxidative genes. Furthermore, the protein level of oxidative markers in serum samples was assessed. Finally, serum TNF-α concentrations were measured using the ELISA technique. The expression levels of SOD1, SOD2, and NRF2 genes were significantly higher on days 15 and 30 compared to the control group (P < 0.05), with a greater increase on day 30 (P < 0.05). Conversely, the expression levels of Keap1 and NOX2 genes were lower on day 30 than those of the control group (P < 0.05), with a further decrease from day 15 to day 30 (P < 0.05). The experimental group exhibited a notable reduction in TNF-α cytokine levels on day 30 compared to the control and placebo groups (P < 0.05). All findings were coordinated according to the nutritional questionnaire. Our findings suggest a potential benefit of zinc supplementation in managing the adverse effects of chemotherapy in MM patients, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Faculty of Biology, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran.
- Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. mahshid_mehdizadeh@yahoo.com.
- Department of Biostatistics, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Förderung
- Hematopoietic stem cell research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Zitieren
APA
Jahankhani, K., Taghipour, N., Nikoonezhad, M., Behboudi, H., Mehdizadeh, M., Kadkhoda, D., Hajifathali, A., & Mosaffa, N. (2024). Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial. BioMetals. https://doi.org/10.1007/s10534-024-00630-0
Vancouver
Jahankhani K, Taghipour N, Nikoonezhad M, Behboudi H, Mehdizadeh M, Kadkhoda D, et al. Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial. BioMetals. 2024. doi:10.1007/s10534-024-00630-0
BibTeX
@article{Jahankhani2024,
author = {Jahankhani, Kasra and Taghipour, Niloofar and Nikoonezhad, Maryam and Behboudi, Hossein and Mehdizadeh, Mahshid and Kadkhoda, Dariush and Hajifathali, Abbas and Mosaffa, Nariman},
title = {Adjuvant therapy with zinc supplementation; anti-inflammatory and anti-oxidative role in multiple myeloma patients receiving autologous hematopoietic stem cell transplantation: a randomized controlled clinical trial},
journal = {BioMetals},
year = {2024},
doi = {10.1007/s10534-024-00630-0}
}
EUVIMED